[1]
Ucciferri, C. et al. 2022. Improving BNT162b2 mRNA vaccine tolerability without efficacy loss by Pidotimod supplementation: Pidotimod in SARS-CoV-2 vaccination. Mediterranean Journal of Hematology and Infectious Diseases. 14, 1 (Feb. 2022), e2022023. DOI:https://doi.org/10.4084/MJHID.2022.023.